UNSPSC 51263126: Metipranolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X39AL81KEB, chemically known as 4-(2-hydroxy-3-((1-methylethyl)-amino)propoxy)-2,3,6-trimethylphenol 1-acetate but generally known as metipranolol, which bears US NIH Compound Identifier 31477. European Medicines Agency schedules Metipranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08892MIG.

UNSPSC 51263126 Metipranolol is a Commodity code that state and local governments are not actively procuring under. The two recent opportunities tagged to this code—Seminole County's IFB for naloxone and drug deactivation systems, and the Texas Health and Human Services Commission's RFI on direct-to-manufacturer prescription programs—involve naloxone (an opioid antagonist used for overdose reversal) and pharmacy benefit management infrastructure, neither of which relate to metipranolol, a beta-blocking glaucoma medication. The tagging appears to reflect a systematic mismatch between the code's nominal scope and actual state and local purchasing activity under it.

The code shows no recent opportunities for metipranolol procurement itself. Given the sparse and unrelated activity in the recent-opportunities block, this code warrants a watch rather than immediate pursuit; monitor whether state agencies, counties, school districts, or other jurisdictions begin issuing formal solicitations—RFPs, RFQs, or ITBs—explicitly requesting metipranolol or other glaucoma therapeutics for state health plans, correctional facilities, or community health programs.